I need to respond to a discussion post from one of my peers.My peer wrote: “Tw

ORDER YOUR PAPER AND GET QUALITY FOR YOUR MONEY

I need to respond to a discussion post from one of my peers.My peer wrote:“Two common risk factors in polypharmacy are multimorbidity and frailty.Multimorbidity: refers to the clinical occurrence where a patient has two or more chronic conditions. Patients above the age of seventy are more likely to develop two or more chronic conditions as a result of old age. With reference to polypharmacy, the research has shown that where a patient has more than five chronic conditions, the risk of polypharmacy increases (Dening, 2018).Frailty: refers to the progressive decline in health and perceived proper body functioning, especially in older patients. As a result of frailty, patients are predisposed to chronic illnesses, resulting in polypharmacy because they need medication for all the conditions (Vellas & Sourdet, 2017).In my clinical practice, I would employ two main interventions to prevent polypharmacy and the complications resulting from polypharmacy. First, I would encourage record-keeping practice for the patients. The records would include all the over-the-counter drugs and prescription drugs. This would help them with dosing frequency to avoid missing a dose, leading to the progression of the current conditions or the development of another condition. Lastly, I would encourage medication adherence by the patients. Medication adherence requires patients to understand why they are taking certain medications and the consequences of nonadherence to the drugs (Chaplin,2021).”